- Home
- INSP vs ALKS Comparison
INSP vs ALKS Comparison
Compare INSP & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSP
- ALKS
- Stock Information
- Founded
- INSP 2007
- ALKS 1987
- Country
- INSP United States
- ALKS Ireland
- Employees
- INSP N/A
- ALKS N/A
- Industry
- INSP Medical/Dental Instruments
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- INSP Health Care
- ALKS Health Care
- Exchange
- INSP Nasdaq
- ALKS Nasdaq
- Market Cap
- INSP 5.2B
- ALKS 4.4B
- IPO Year
- INSP 2018
- ALKS 1991
- Fundamental
- Price
- INSP $172.77
- ALKS $28.17
- Analyst Decision
- INSP Buy
- ALKS Buy
- Analyst Count
- INSP 11
- ALKS 12
- Target Price
- INSP $226.18
- ALKS $35.42
- AVG Volume (30 Days)
- INSP 570.0K
- ALKS 1.9M
- Earning Date
- INSP 11-04-2024
- ALKS 10-24-2024
- Dividend Yield
- INSP N/A
- ALKS N/A
- EPS Growth
- INSP N/A
- ALKS 55.25
- EPS
- INSP 1.09
- ALKS 1.97
- Revenue
- INSP $755,594,000.00
- ALKS $1,505,121,000.00
- Revenue This Year
- INSP $29.96
- ALKS N/A
- Revenue Next Year
- INSP $19.42
- ALKS N/A
- P/E Ratio
- INSP $157.93
- ALKS $12.33
- Revenue Growth
- INSP 32.52
- ALKS N/A
- 52 Week Low
- INSP $123.00
- ALKS $22.22
- 52 Week High
- INSP $257.40
- ALKS $32.88
- Technical
- Relative Strength Index (RSI)
- INSP 34.22
- ALKS 49.75
- Support Level
- INSP $196.12
- ALKS $28.10
- Resistance Level
- INSP $204.93
- ALKS $30.30
- Average True Range (ATR)
- INSP 10.27
- ALKS 0.84
- MACD
- INSP -2.67
- ALKS 0.11
- Stochastic Oscillator
- INSP 5.77
- ALKS 50.32
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.